Cost-Effectiveness of Laparoscopic Sleeve Gastrectomy for Chinese Patients

Overview

Journal Obes Surg

Date 2024 Jul 9

PMID 38981958

Authors

Weihua Yu

Jionghuang Chen

Luqi Fan

Chenli Yan

Linghua Zhu

Affiliations

Soon will be listed here.

Abstract

Background: Laparoscopic sleeve gastrectomy (LSG) is the most popular bariatric surgery procedure in China. However, its cost-effectiveness in Chinese patients is currently unknown.

Objectives: This study aims to assess the cost-effectiveness of LSG vs no surgery in Chinese patients with severe and complex obesity, taking into account both healthcare expenses and the potential improvement in health-related quality of life (HRQoL).

Methods: A retrospective cohort study was conducted, encompassing 135 Chinese patients who underwent LSG between January 3, 2022 and December 29, 2022, at a major bariatric center. The study evaluated the cost-effectiveness from a healthcare service perspective, employing the incremental cost-effectiveness ratio (ICER) for quality-adjusted life years (QALYs) gained. The analyses compared LSG with the alternative of not undergoing surgery over a 1-year period, using actual data, and extended to a lifetime horizon by projecting costs and utilities at an annual discount rate of 3.0%. Subgroup analyses were undertaken to explore cost-effectiveness variations across different sex, age and BMI categories, and diabetes status, employing a one-way analysis of variance (ANOVA). To ensure the reliability of the findings, one-way and probabilistic sensitivity analyses were executed.

Results: The results indicated that 1-year post-LSG, patients achieved an average total weight loss (TWL) of (32.7 ± 7.3)% and an excess weight loss (EWL) of (97.8 ± 23.1)%. The ICER for LSG compared to no surgery over a lifetime was $4,327/QALY, significantly below the willingness-to-pay (WTP) threshold for Chinese patients with severe and complex obesity. From a lifetime perspective, LSG proved to be cost-effective for all sex and age groups, across all BMI categories, and for both patients with and without diabetes. Notably, it was more cost-effective for younger patients, patients with higher BMI, and patients with diabetes.

Conclusions: LSG is a highly cost-effective intervention for managing obesity in Chinese patients, delivering substantial benefits in terms of HRQoL improvement at a low cost. Its cost-effectiveness is particularly pronounced among younger individuals, those with higher BMI, and patients with diabetes.

Citing Articles

Metabolic syndrome.

Neeland I, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele C Nat Rev Dis Primers. 2024; 10(1):77.

PMID: 39420195 DOI: 10.1038/s41572-024-00563-5.

References

Friedrich M . Global Obesity Epidemic Worsening. JAMA. 2017; 318(7):603. DOI: 10.1001/jama.2017.10693. View

Ohta M, Ahn S, Seki Y, Yang W, Wong S, Udomsawaengsup S . Ten Years of Change in Bariatric/Metabolic Surgery in the Asia-Pacific Region with COVID-19 Pandemic: IFSO-APC National Reports 2021. Obes Surg. 2022; 32(9):2994-3004. PMC: 9245878. DOI: 10.1007/s11695-022-06182-x. View

Tian P, Fu J, Li M, Liu Y, Bian S, Zhang M . Metabolic and bariatric surgery in China: A summary of the Greater China Metabolic and Bariatric Surgery Database and comparison with other international registry databases. Diabetes Obes Metab. 2023; 25 Suppl 1:27-33. DOI: 10.1111/dom.15012. View

Franco J, Ruiz P, Palermo M, Gagner M . A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding. Obes Surg. 2011; 21(9):1458-68. DOI: 10.1007/s11695-011-0390-5. View

Tu Y, Wang L, Wei L, Xu Y, Han X, Han J . Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort. Obes Surg. 2019; 29(12):3978-3986. DOI: 10.1007/s11695-019-04069-y. View

Klebanoff M, Chhatwal J, Nudel J, Corey K, Kaplan L, Hur C . Cost-effectiveness of Bariatric Surgery in Adolescents With Obesity. JAMA Surg. 2016; 152(2):136-141. DOI: 10.1001/jamasurg.2016.3640. View

Alsumali A, Eguale T, Bairdain S, Samnaliev M . Cost-Effectiveness Analysis of Bariatric Surgery for Morbid Obesity. Obes Surg. 2018; 28(8):2203-2214. DOI: 10.1007/s11695-017-3100-0. View

Borisenko O, Lukyanov V, Ahmed A . Cost-utility analysis of bariatric surgery. Br J Surg. 2018; 105(10):1328-1337. DOI: 10.1002/bjs.10857. View

Alsumali A, Al-Hawag A, Samnaliev M, Eguale T . Systematic assessment of decision analytic models for the cost-effectiveness of bariatric surgery for morbid obesity. Surg Obes Relat Dis. 2018; 14(7):1041-1059. DOI: 10.1016/j.soard.2018.03.005. View

10.

Xu Y, Zhou Z, Li Y, Yang J, Guo X, Gao J . Exploring the nonlinear relationship between body mass index and health-related quality of life among adults: a cross-sectional study in Shaanxi Province, China. Health Qual Life Outcomes. 2015; 13:153. PMC: 4580353. DOI: 10.1186/s12955-015-0347-9. View

11.

Qin X, Pan J . The Medical Cost Attributable to Obesity and Overweight in China: Estimation Based on Longitudinal Surveys. Health Econ. 2015; 25(10):1291-311. DOI: 10.1002/hec.3217. View

12.

Jones J, Takeda A, Picot J, Von Keyserlingk C, Clegg A . Lapatinib for the treatment of HER2-overexpressing breast cancer. Health Technol Assess. 2009; 13 Suppl 3:1-6. DOI: 10.3310/hta13suppl3/01. View

13.

Pokala B, Hernandez E, Giannopoulos S, Athanasiadis D, Timsina L, Sorg N . Early postoperative weight loss predicts nadir weight and weight regain after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Endosc. 2022; 37(6):4934-4941. DOI: 10.1007/s00464-022-09658-0. View

14.

Lauti M, Kularatna M, Hill A, MacCormick A . Weight Regain Following Sleeve Gastrectomy-a Systematic Review. Obes Surg. 2016; 26(6):1326-34. DOI: 10.1007/s11695-016-2152-x. View